Aardvark Therapeutics, Inc. (AARD) Stock

NASDAQ: AARDHealthcare company in the biotechnology industry, based in San Diego, CA.

Aardvark Therapeutics stock price chart

AARD interactive chart →

AARD stock quote & key statistics

Aardvark Therapeutics earnings per share

Income →
Earnings per share

Aardvark Therapeutics revenue & net income

Income →
RevenueNet income

Aardvark Therapeutics annual financials

Income statement →
Fiscal yearRevenueNet incomeEPS
FY2025$0-$57.6M-$2.93
FY2024$0-$20.6M-$0.43
FY2023$0-$7.2M—
FY2022$0-$13.6M—

Fiscal year ending December 31. Source: company filings via EODHD.

About Aardvark Therapeutics, Inc.

Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. Aardvark Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, California.

Aardvark Therapeutics stock FAQ

What is the Aardvark Therapeutics stock ticker symbol?

Aardvark Therapeutics, Inc. trades on the NASDAQ under the ticker symbol AARD.

What sector and industry is Aardvark Therapeutics in?

Aardvark Therapeutics, Inc. is classified in the Healthcare sector, Biotechnology industry.

How many employees does Aardvark Therapeutics have?

Aardvark Therapeutics, Inc. has about 28 full-time employees.

What were Aardvark Therapeutics's revenue and earnings last fiscal year?

Aardvark Therapeutics reported revenue of $0 and net income of -$57.6M in fiscal 2025, with earnings per share of -$2.93.

When did Aardvark Therapeutics go public?

Aardvark Therapeutics stock began trading on February 13, 2025.

Biotechnology stocks

All Healthcare stocks →